4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-040099
Chief Scientific Officer sold 7,790 shares at an average $35.56 ($277,048)
- Chief Scientific Officer acquired 7,790 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-05 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-05 | Sale | −3,895 | $35.43 | $138,000 | 69,360 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-06 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-06 | Sale | −3,048 | $35.51 | $108,234 | 70,207 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-06 | Sale | −847 | $36.38 | $30,814 | 69,360 | D: show line 5 in the form |
| Open-market sales · 7,790 sh · avg $35.56 · $277,048 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-05 | Option exercise · Stock Option (Right to Buy) | −3,895 | 132,430 | D: show line 6 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-06 | Option exercise · Stock Option (Right to Buy) | −3,895 | 128,535 | D: show line 7 in the form |
Loading xslF345X03/doc4a.xml…